+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Phenotypic assays and sequencing are less sensitive than point mutation assays for detection of resistance in mixed HIV-1 genotypic populations



Phenotypic assays and sequencing are less sensitive than point mutation assays for detection of resistance in mixed HIV-1 genotypic populations



Journal of Acquired Immune Deficiency Syndromes 22(2): 107-118



The sensitivity and discriminatory power of the 151 and 215 amplification refractory mutation system (ARMS) were evaluated, and their performance for the detection of drug resistance in mixed genotypic populations of the reverse transcription (RT) gene of HIV-1 were compared with T7 sequencing, cycle sequencing, the line probe assay (LiPA) HIV-1 RT test, and the recombinant virus assay (RVA). ARMS and the LiPA HIV-1 RT test were shown to be able to detect minor variants that in particular cases comprised only 1%. T7 sequencing on an ALF semiautomated sequencer could correctly score mixtures only when variants were present at 50%. Cycle sequencing on an ABI PRISM 310 improved the sensitivity for mixtures to about 25%. Using RVA, it was shown that at least 50% of the virus population needed to carry the resistance mutation at codon 184 to afford phenotypic resistance against lamivudine. The two point mutation assays therefore proved to be more sensitive methods than sequencing and RVA to reliably determine a gradual shift in HIV-1 drug resistance mutations in follow-up of patients infected with HIV-1. In 4 of 5 treated patients who were followed by ARMS, a gradual shift in resistant genotypic populations was observed during a period of 6 to 19 months. For 1 patient, a shift from wild to mutant type at position 151 occurred within 2 months, without mixed genotypic intermediate type's being detected.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 046973963

Download citation: RISBibTeXText

PMID: 10843523


Related references

Phenotypic assays and sequencing are less sensitive for the detection of resistance in mixed genotypes compared to point mutation assays. AIDS 12(Suppl. 4): S26, 1998

HIV-1 viral load and phenotypic antiretroviral drug resistance assays based on reverse transcriptase activity in comparison to amplification based HIV-1 RNA and genotypic assays. Journal of Clinical Virology 47(1): 18-22, 2010

Performance of commonly used genotypic assays and comparison with phenotypic assays of HIV-1 coreceptor tropism in acutely HIV-1-infected patients. Journal of Antimicrobial ChemoTherapy 70(5): 1391-1395, 2015

Detection of induced male germline mutation: correlations and comparisons between traditional germline mutation assays, transgenic rodent assays and expanded simple tandem repeat instability assays. Mutation Research 598(1-2): 164-193, 2006

Phenotypic and genotypic resistance assays: Methodology, reliability, and interpretations. JAIDS Journal of Acquired Immune Deficiency Syndromes 26(Suppl. 1): S3-S9, 2001

International perspectives on antiretroviral resistance. Phenotypic and genotypic resistance assays: methodology, reliability, and interpretations. Journal of Acquired Immune Deficiency Syndromes 26(Suppl. 1): S3-S9, 2001

Phenotypic and genotypic HIV-1 drug resistance assays provide complementary information. Journal of Acquired Immune Deficiency Syndromes 31(2): 128-136, 2002

Phenotypic and genotypic assays for the detection and identification of adhesins from pyelonephritic Escherichia coli. Annales de l'Institut Pasteur. Microbiology 139(5): 557-573, 1988

Use of genotypic assays for the detection of HIV antiretroviral resistance. Scandinavian Journal of Infectious Diseases. Supplementum 106: 24-28, 2003

Use of genotypic assays for the detection of Hiv antiretroviral resistance. Scandinavian Journal of Infectious Diseases 35(11): 24-28, 2003

Comprehensive HIV drug resistance monitoring using rapid, high-throughput phenotypic and genotypic assays with correlative data analysis. AIDS 12(Suppl. 4): S11, 1998

Use of genotypic assays for the detection of antiretroviral resistance: a legal proceeding, Rome, 22-23 April 2002. Scandinavian Journal of Infectious Diseases. Supplementum 106: 5, 2003

A randomized controlled trial of the value of phenotypic testing in addition to genotypic testing for HIV drug resistance: evaluation of resistance assays (ERA) trial investigators. Journal of Acquired Immune Deficiency Syndromes 38(5): 553-559, 2005

The biologic lower detection limit of six ultra-sensitive PSA assays - no advantage to ultra-sensitive assays?. Anticancer Research 17(6C): 4200, 1997

Identification of a 55-bp deletion in the glucocerebrosidase gene in Gaucher disease: phenotypic presentation and implications for mutation detection assays. Molecular Genetics and Metabolism 72(3): 248-253, 2001